1.Zhang Qi, Ju Bin, Ge Jiwan, Chan Jasper Fuk-Woo, Cheng Lin, Wang Ruoke, Huang Weijin, Fang Mengqi, Chen Peng, Zhou Bing, Song Shuo, Shan Sisi, Yan Baohua, Zhang Senyan, Ge Xiangyang, Yu Jiazhen, Zhao Juanjuan, Wang Haiyan, Liu Li, Lv Qining, Fu Lili, Shi Xuanling, Yuen Yung Kwok, Liu Lei, Wang Youchun, Chen Zhiwei, Zhang Linqi, Wang Xinquan, Zhang Zheng. (2021). Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2. Nature Communications, 12, 1–12. https://doi.org/10.1038/s41467-021-24514-w
2.Li Mingxi, Guo Jingao, Lu Shuaiyao, Zhou Runhong, Shi Hongyang, Shi Xuanling, Cheng Lin, Liang Qingtai, Liu Hongqi, Wang Pui, Wang Nan, Wang Yifeng, Fu Lili, Xing Man, Wang Ruoke, Ju Bin, Liu Li, Lau Siu-Ying, Jia Wenxu, Tong Xin, Yuan Lin, Guo Yong, Qi Hai, Zhang Qi, Huang Zhen, Chen Honglin, Zhang Zheng, Chen Zhiwei, Peng Xiaozhong, Zhou Dongming, Zhang Linqi. (2021). Single-dose immunization with a chimpanzee adenovirus-based vaccine induces sustained and protective immunity against SARS-CoV-2 infection. Frontiers in Immunology, 12, 1–14. https://doi.org/10.3389/fimmu.2021.697074
3.Wang Ruoke, Zhang Qi, Ge Jiwan, Ren Wenlin, Zhang Rui, Lan Jun, Ju Bin, Su Bin, Yu Fengting, Chen Peng, Liao Huiyu, Feng Yingmei, Li Xuemei, Shi Xuanling, Zhang Zheng, Zhang Fujie, Ding Qiang, Zhang Tong, Wang Xinquan, Zhang Linqi. (2021). Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species. Immunity. https://doi.org/10.1016/j.immuni.2021.06.003
4.Yan Renhong, Wang Ruoke, Ju Bin, Yu Jinfang, Zhang Yuanyuan, Liu Nan, Wang Jia, Zhang Qi, Chen Peng, Zhou Bing, Li Yaning, Shen Yaping, Zhang Shuyuan, Tian Long, Guo Yingying, Xia Lu, Zhong Xinyue, Cheng Lin, Ge Xiangyang, Zhao Juajuan, Wang Hong-Wei, Wang Xinquan, Zhang Zheng, Zhang Linqi, Zhou Qiang. (2021). Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies. Cell Research, 31(5), 517–525. https://doi.org/10.1038/s41422-021-00487-9
5.Ge Jiwan, Wang Ruoke, Ju Bin, Zhang Qi, Sun Jing, Chen Peng, Zhang Senyan, Tian Yuling, Shan Sisi, Cheng Lin, Zhou Bing, Song Shuo, Zhao Juanjuan, Wang Haiyan, Shi Xuanling, Ding Qiang, Liu Lei, Zhao Jincun, Zhang Zheng, Wang Xinquan, Zhang Linqi. (2021). Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry. Nature Communications, 12(1), 1–9. https://doi.org/10.1038/s41467-020-20501-9
6.Ju Bin, Zhang Qi, Ge Jiwan, Wang Ruoke, Sun Jing, Ge Xiangyang, Yu Jiazhen, Shan Sisi, Zhou Bing, Song Shuo, Tang Xian, Yu Jinfang, Lan Jun, Yuan Jing, Wang Haiyan, Zhao Juanjuan, Zhang Shuye, Wang Youchun, Shi Xuanling, Liu Lei, Zhao Jincun, Wang Xinquan, Zhang Zheng, Zhang Linqi. (2020). Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature, 584(7819), 115–119. https://doi.org/10.1038/s41586-020-2380-z
7.Lan Jun, Ge Jiwan, Yu Jinfang, Shan Sisi, Zhou Huan, Fan Shilong, Zhang Qi, Shi Xuanling, Wang Qisheng, Zhang Linqi, Wang Xinquan. (2020). Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature, 581(7807), 215–220. https://doi.org/10.1038/s41586-020-2180-5
8.Wang Qian, Zhang Linqi. (2020). Broadly neutralizing antibodies and vaccine design against HIV-1 infection. Frontiers of Medicine, 14(1), 30–42. https://doi.org/10.1007/s11684-019-0721-9
9.Zhou Panpan, Wang Han, Fang Mengqi, Li Yangyang, Wang Hua, Shi Shasha, Li Zihao, Wu Jiapeng, Han Xiaoxu, Shi Xuanling, Shang Hong, Zhou Tongqing, Zhang Linqi. (2019). Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies. PLoS Pathogens, 15(6), 1–24. https://doi.org/10.1371/journal.ppat.1007819
10.Xu Jiuyang, Jia Wenxu, Wang Pengfei, Zhang Senyan, Shi Xuanling, Wang Xinquan, Zhang Linqi. (2019). Antibodies and vaccines against Middle East respiratory syndrome coronavirus. Emerging Microbes and Infections, 8(1), 841–856. https://doi.org/10.1080/22221751.2019.1624482
11.Wang Qian, Liu Lihong, Ren Wuze, Gettie Agegnehu, Wang Hua, Liang Qingtai, Shi Xuanling, Montefiori David C., Zhou Tongqing, Zhang Linqi. (2019). A single substitution in gp41 modulates the neutralization profile of SHIV during in vivo adaptation. Cell Reports, 27(9), 2593-2607.e5. https://doi.org/10.1016/j.celrep.2019.04.108
12.Jia Wenxu, Channappanavar Rudragouda, Zhang Chao, Li Mingxi, Zhou Haixia, Zhang Shuyuan, Zhou Panpan, Xu Jiuyang, Shan Sisi, Shi Xuanling, Wang Xinquan, Zhao Jincun, Zhou Dongming, Perlman Stanley, Zhang Linqi. (2019). Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection. Emerging Microbes and Infections, 8(1), 760–772. https://doi.org/10.1080/22221751.2019.1620083
13.Li Guanqiao, Jiang Yan, Zhang Linqi. (2019). HIV upsurge in China’s students. Science (New York, N.Y.), 364(6442), 711. https://doi.org/10.1126/science.aay0799
14.Wang Pengfei, Zuo Yanan, Sun Jianfeng, Zuo Teng, Zhang Senyan, Guo Shichun, Shi Xuanling, Liang Mifang, Zhou Paul, Zhang Linqi, Wang Xinquan. (2019). Structural and functional definition of a vulnerable site on the hemagglutinin of highly pathogenic avian influenza A virus H5N1. Journal of Biological Chemistry, 294(12), 4290–4303. https://doi.org/10.1074/jbc.RA118.007008
15.Wang Lin, Wang Ruoke, Wang Lei, Ben Haijing, Yu Lei, Gao Fei, Shi Xuanling, Yin Chibiao, Zhang Fuchun, Xiang Ye, Zhang Linqi. (2019). Structural basis for neutralization and protection by a Zika virus-specific human antibody. Cell Reports, 26(12), 3360-3368.e5. https://doi.org/10.1016/j.celrep.2019.02.062
16.Zuo Yanan, Wang Pengfei, Sun Jianfeng, Guo Shichun, Wang Guiqin, Zuo Teng, Fan Shilong, Zhou Paul, Liang Mifang, Shi Xuanling, Wang Xinquan, Zhang Linqi. (2018). Complementary recognition of the receptor-binding site of highly pathogenic H5N1 influenza viruses by two human neutralizing antibodies. Journal of Biological Chemistry, 293(42), 16503–16517. https://doi.org/10.1074/jbc.RA118.004604
17.Zhang Senyan, Zhou Panpan, Wang Pengfei, Li Yangyang, Jiang Liwei, Jia Wenxu, Wang Han, Fan Angela, Wang Dongli, Shi Xuanling, Fang Xianyang, Hammel Michal, Wang Shuying, Wang Xinquan, Zhang Linqi. (2018). Structural definition of a unique neutralization epitope on the receptor-binding domain of MERS-CoV spike glycoprotein. Cell Reports, 24(2), 441–452. https://doi.org/10.1016/j.celrep.2018.06.041
18.Niu Peihua, Zhang Senyan, Zhou Panpan, Huang Baoying, Deng Yao, Qin Kun, Wang Pengfei, Wang Wenling, Wang Xinquan, Zhou Jianfang, Zhang Linqi, Tan Wenjie. (2018). Ultrapotent human neutralizing antibody repertoires against Middle East respiratory syndrome coronavirus from a recovered patient. Journal of Infectious Diseases, 218(8), 1249–1260. https://doi.org/10.1093/infdis/jiy311
19.Li Cui, Gao Fei, Yu Lei, Wang Ruoke, Jiang Yisheng, Shi Xuanling, Yin Chibiao, Tang Xiaoping, Zhang Fuchun, Xu Zhiheng, Zhang Linqi. (2018). A single injection of human neutralizing antibody protects against Zika virus infection and microcephaly in developing mouse embryos. Cell Reports, 23(5), 1424–1434. https://doi.org/10.1016/j.celrep.2018.04.005
20.Wang Hua, Chen Xiangjun, Wang Dianhong, Yao Chen, Wang Qian, Xie Jiayu, Shi Xuanling, Xiang Ye, Liu Wanli, Zhang Linqi. (2018). Epitope-focused immunogens against the CD4-binding site of HIV-1 envelope protein induce neutralizing antibodies against auto- and heterologous viruses. Journal of Biological Chemistry, 293(3), 830–846. https://doi.org/10.1074/jbc.M117.816447
21.Yu Lei, Wang Ruoke, Gao Fei, Li Min, Liu Jianying, Wang Jian, Hong Wenxin, Zhao Lingzhai, Wen Yingfen, Yin Chibiao, Wang Hua, Zhang Qi, Li Yangyang, Zhou Panpan, Zhang Rudian, Liu Yang, Tang Xiaoping, Guan Yongjun, Qin Cheng-Feng, Chen Ling, Shi Xuanling, Jin Xia, Cheng Gong, Zhang Fuchun, Zhang Linqi. (2017). Delineating antibody recognition against Zika virus during natural infection. Journal of Clinical Investigation, 2(12), 1–16. https://doi.org/10.1172/jci.insight.93042
22.Zhang Qi, Gui Miao, Niu Xuefeng, He Shihua, Wang Ruoke, Feng Yupeng, Kroeker Andrea, Zuo Yanan, Wang Hua, Wang Ying, Li Jiade, Li Chufang, Shi Yi, Shi Xuanling, Gao George F., Xiang Ye, Qiu Xiangguo, Chen Ling, Zhang Linqi. (2016). Potent neutralizing monoclonal antibodies against Ebola virus infection. Scientific Reports, 6, 1–15. https://doi.org/10.1038/srep25856
23.Jin Su, Ji Yangtao, Wang Qian, Wang Hua, Shi Xuanling, Han Xiaoxu, Zhou Tongqing, Shang Hong, Zhang Linqi. (2016). Spatiotemporal hierarchy in antibody recognition against transmitted HIV-1 envelope glycoprotein during natural infection. Retrovirology, 13(1), 11. https://doi.org/10.1186/s12977-016-0243-3
24.Zuo Teng, Sun Jianfeng, Wang Guiqin, Jiang Liwei, Zuo Yanan, Li Danyang, Shi Xuanling, Liu Xi, Fan Shilong, Ren Huanhuan, Hu Hongxing, Sun Lina, Zhou Boping, Liang Mifang, Zhou Paul, Wang Xinquan, Zhang Linqi. (2015). Comprehensive analysis of antibody recognition in convalescent humans from highly pathogenic avian influenza H5N1 infection. Nature Communications, 6. https://doi.org/10.1038/ncomms9855
25.Jiang Liwei, Wang Nianshuang, Zuo Teng, Shi Xuanling, Poon Kwok Man Vincent, Wu Yongkang, Gao Fei, Li Danyang, Wang Ruoke, Guo Jianying, Fu Lili, Yuen Kwok Yung, Zheng Bo Jian, Wang Xinquan, Zhang Linqi. (2014). Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein. Science Translational Medicine, 6(234). https://doi.org/10.1126/scitranslmed.3008140
26.Wang Nianshuang, Shi Xuanling, Jiang Liwei, Zhang Senyan, Wang Dongli, Tong Pei, Guo Dongxing, Fu Lili, Cui Ye, Liu Xi, Arledge Kelly C., Chen Ying Hua, Zhang Linqi, Wang Xinquan. (2013). Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Research, 23(8), 986–993. https://doi.org/10.1038/cr.2013.92
27.Sun Caijun, Chen Zhiwei, Tang Xian, Zhang Yinfeng, Feng Liqiang, Du Yanhua, Xiao Lijun, Liu Li, Zhu Weijun, Chen Ling, Zhang Linqi. (2013). Mucosal priming with a replicating-vaccinia virus-Based vaccine elicits protective immunity to simian immunodeficiency virus challenge in rhesus monkeys. Journal of Virology, 87(10), 5669–5677. https://doi.org/10.1128/jvi.03247-12
28.Hong Shang, Junjie Xu, Xiaoxu Han, Jessica Spero Li, Kelly C Arledge, Linqi Zhang. (2012). HIV prevention: Bring safe sex to China. Nature, 485, 576-577. https://doi.org/10.1038/485576a.
29.Guo Dongxing, Shi Xuanling, Arledge Kelly C., Song Dingka, Jiang Liwei, Fu Lili, Gong Xinqi, Zhang Senyan, Wang Xinquan, Zhang Linqi. (2012). A single residue within the V5 region of HIV-1 envelope facilitates viral escape from the broadly neutralizing monoclonal antibody VRC01. Journal of Biological Chemistry, 287(51), 43170–43179. https://doi.org/10.1074/jbc.M112.399402
30.Zuo Teng, Shi Xuanling, Liu Zhonghua, Guo Linlin, Zhao Qing, Guan Tianxia, Pan Xianming, Jia Na, Cao Wuchun, Zhou Boping, Goldin Mark, Zhang Linqi. (2011). Comprehensive analysis of pathogen-specific antibody response in vivo based on an antigen library displayed on surface of yeast. Journal of Biological Chemistry, 286(38), 33511–33519. https://doi.org/10.1074/jbc.M111.270553
31.Shang Hong, Han Xiaoxu, Shi Xuanling, Zuo Teng, Goldin Mark, Chen Dan, Han Bing, Sun Wei, Wu Hao, Wang Xinquan, Zhang Linqi. (2011). Genetic and neutralization sensitivity of diverse HIV-1 env clones from chronically infected patients in China. Journal of Biological Chemistry, 286(16), 14531–14541. https://doi.org/10.1074/jbc.M111.224527
32.Liu Zhonghua, Shan Mei, Li Li, Lu Lu, Meng Shu, Chen Cheng, He Yuxian, Jiang Shibo, Zhang Linqi. (2011). In vitro selection and characterization of HIV-1 variants with increased resistance to sifuvirtide, a novel HIV-1 fusion inhibitor. Journal of Biological Chemistry, 286(5), 3277–3287. https://doi.org/10.1074/jbc.M110.199323
33.Lu Lin, Jia Manhong, Ma Yanling, Yang Li, Chen Zhiwei, Ho David D., Jiang Yan, Zhang Linqi. (2008). The changing face of HIV in China. Nature, 455(7213), 609–611. https://doi.org/10.1038/455609a
34.He Yuxian, Xiao Yonghong, Song Haifeng, Liang Qing, Ju Dan, Chen Xin, Lu Hong, Jing Weiguo, Jiang Shibo, Zhang Linqi. (2008). Design and evaluation of sifuvirtide, a novel HIV-1 fusion inhibitor. Journal of Biological Chemistry, 283(17), 11126–11134. https://doi.org/10.1074/jbc.M800200200
35.Chen Hannah Yuan, Di Mascio Michele, Perelson Alan S., Ho David D., Zhang Linqi. (2007). Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques. Proceedings of the National Academy of Sciences of the United States of America, 104(48), 19079–19084. https://doi.org/10.1073/pnas.0707449104
36.Arron Sarah Tuttleton, Ribeiro Ruy M., Gettie Agegnehu, Bohm Rudolf, Blanchard James, Yu Jian, Perelson Alan S., Ho David D., Zhang Linqi. (2005). Impact of thymectomy on the peripheral T cell pool in rhesus macaques before and after infection with simian immunodeficiency virus. European Journal of Immunology, 35(1), 46–55. https://doi.org/10.1002/eji.200424996
37.Poles Michael A., Barsoum Shady, Yu Wenjie, Yu Jian, Sun Patricia, Daly Jeanine, He Tian, Mehandru Saurabh, Talal Andrew, Markowitz Martin, Hurley Arlene, Ho David, Zhang Linqi. (2003). Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood γδ T cells despite suppressive therapy. Journal of Virology, 77(19), 10456–10467. https://doi.org/10.1128/jvi.77.19.10456-10467.2003
38.Zhang Linqi, Chung Chris, Hu Bor Shen, He Tian, Guo Yong, Kim Alexandria J., Skulsky Eva, Jin Xia, Hurley Arlene, Ramratnam Bharat, Markowitz Martin, Ho David D. (2000). Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy. Journal of Clinical Investigation, 106(7), 839–845. https://doi.org/10.1172/JCI10565
39.Ho David D., Zhang Linqi. (2000). HIV-1 rebound after anti-retroviral therapy. Nature Medicine, 6(7), 736–737. https://doi.org/10.1038/77447
40.Zhang Linqi, Lewin Sharon R., Markowitz Martin, Lin Hsi Hsun, Skulsky Eva, Karanicolas Rose, Yuxian He, Xia Jin, Tuttleton Sarah, Vesanen Mika, Spiegel Hans, Kost Rhonda, Van Lunzen Jan, Stellbrink Hans Juergen, Wolinsky Steven, Borkowsky William, Palumbo Paul, Kostrikis Leondios G., Ho David D. (1999). Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. Journal of Experimental Medicine, 190(5), 725–732. https://doi.org/10.1084/jem.190.5.725
41.Zhang Linqi, Ramratnam Bharat, Tenner-Racz Klara, He Yuxian, Vesanen Mika, Lewin Sharon, Talal Andrew, Racz Paul, Perelson Alan S., Korber Bette T., Markowitz Martin, Guo Yong, Duran Margarita, Hurley Arlene, Tsay John, Huang Yu-Ching, Wang Chia-Ching, Ho David D. (1999). Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. New England Journal of Medicine, 340(21), 1605–1613. https://doi.org/10.1056/nejm199905273402101
42.Zhang Linqi, He Tian, Huang Yaoxing, Chen Zhiwei, Guo Young, Wu Sam, Kunstman Kevin J., Brown R. Clark, Phair John P., Neumann Avidan U., Ho David D., Wolinsky Steven M. (1998). Chemokine Coreceptor Usage by Diverse Primary Isolates of Human Immunodeficiency Virus Type 1. Journal of Virology, 72(11), 9307–9312. https://doi.org/10.1128/jvi.72.11.9307-9312.1998
43.Zhang Linqi, Huang Yaoxing, He Tian, Cao Yunzhen, Ho David D. (1996). HIV-1 subtype and second-receptor use. Nature, 383, 31.
44.Zhang Linqi, MacKenzie P, Cleland A, Holmes E C, Brown A J, Simmonds P. (1993). Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. Journal of Virology, 67(6), 3345–3356. https://doi.org/10.1128/jvi.67.6.3345-3356.1993
45.Zhang, Linqi; Simmonds, Peter; Ludlam, Christopher A.; Brown Andrew J. Leigh. (1991). Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates. AIDS, 5(6), 675–681.
